Mo HY - Search Results

1

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.

Liu LT, Chen QY, Tang LQ, Guo SS, Guo L, Mo HY, Chen MY, Zhao C, Guo X, Qian CN, Zeng MS, Bei JX, Tan J, Chen S, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. Liu LT, et al. Among authors: mo hy. Cancer Res Treat. 2018 Jan;50(1):19-29. doi: 10.4143/crt.2016.595. Epub 2017 Apr 5. Cancer Res Treat. 2018. PMID: 28392551 Free PMC article.

2

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.

Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, Lu TX, Mo HY. Ma J, et al. Among authors: mo hy. J Clin Oncol. 2001 Mar 1;19(5):1350-7. doi: 10.1200/JCO.2001.19.5.1350. J Clin Oncol. 2001. PMID: 11230478 Clinical Trial.

3

Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?

Ma J, Mai HQ, Hong MH, Cui NJ, Lu TX, Lu LX, Mo HY, Min HQ. Ma J, et al. Among authors: mo hy. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1181-9. doi: 10.1016/s0360-3016(01)01537-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11483327

4

[Positive rate of radionuclide bone imaging and treatment in no ostalgia patients with new nasopharyngeal carcinoma].

Mo HY, Zhang F, Hong MH, Fan W, Zheng L, Min HQ. Mo HY, et al. Ai Zheng. 2002 Mar;21(3):323-5. Ai Zheng. 2002. PMID: 12452005 Chinese.

5

[Phase I clinical trial evaluation of capecitabine in concurrent combination of radiotherapy in nasopharyngeal carcinoma].

Jiang Y, Hong MH, Deng MQ, Guo L, Cao KJ, Mo HY, Qiu F, Mai HQ, Chen QY, Sun R, Luo DH, Huang PY. Jiang Y, et al. Among authors: mo hy. Ai Zheng. 2004 Apr;23(4):461-6. Ai Zheng. 2004. PMID: 15087040 Clinical Trial. Chinese.

6

[Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].

Mo HY, Zhang CQ, Feng KT, Zhang F, Hong MH, Sun ZY. Mo HY, et al. Ai Zheng. 2004 Nov;23(11 Suppl):1551-4. Ai Zheng. 2004. PMID: 15566678 Chinese.

7

[Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].

Mai HQ, Zeng ZY, Zhang HZ, Hou JH, Mo HY, Guo X, Min HQ, Hong MH. Mai HQ, et al. Among authors: mo hy. Ai Zheng. 2005 May;24(5):611-5. Ai Zheng. 2005. PMID: 15890108 Chinese.

8

[Impact of pre-radiotherapy hemoglobin level on local control of nasopharyngeal carcinoma].

Mai HQ, Mo HY, Hong MH, Guo X, Deng MQ, Zhang F, Min HQ. Mai HQ, et al. Among authors: mo hy. Ai Zheng. 2005 Jun;24(6):727-30. Ai Zheng. 2005. PMID: 15946489 Chinese.

9

[Analysis of oral mucositis risk factors during radiotherapy for nasopharyngeal carcinoma patients and establishment of a discriminant model].

Luo DH, Hong MH, Guo L, Cao KJ, Deng MQ, Mo HY. Luo DH, et al. Among authors: mo hy. Ai Zheng. 2005 Jul;24(7):850-4. Ai Zheng. 2005. PMID: 16004814 Chinese.

10

Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma.

Mai HQ, Zeng ZY, Zhang CQ, Feng KT, Guo X, Mo HY, Deng MQ, Min HQ, Hong MH. Mai HQ, et al. Among authors: mo hy. Cancer. 2006 Apr 1;106(7):1548-53. doi: 10.1002/cncr.21790. Cancer. 2006. PMID: 16518816 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page